Replicative Aging, Telomeres, and Oxidative Stress

Aging is a very complex phenomenon, both in vivo and in vitro. Free radicals and oxidative stress have been suggested for a long time to be involved in or even to be causal for the aging process. Telomeres are special structures at the end of chromosomes. They shorten during each round of replication and this has been characterized as a mitotic counting mechanism. Our experiments show that the rate of telomere shortening in vitro is modulated by oxidative stress as well as by differences in antioxidative defence capacity between cell strains. In vivo we found a strong correlation between short telomeres in blood lymphocytes and the incidence of vascular dementia. These data suggest that parameters that characterise replicative senescence in vitro offer potential for understanding of, and intervention into, the aging process in vivo.

[1]  I. Runnebaum,et al.  Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells , 2001, Cancer Gene Therapy.

[2]  G. Saretzki,et al.  BJ fibroblasts display high antioxidant capacity and slow telomere shortening independent of hTERT transfection. , 2001, Free radical biology & medicine.

[3]  P. Baumann,et al.  Pot1, the Putative Telomere End-Binding Protein in Fission Yeast and Humans , 2001, Science.

[4]  C. Harley,et al.  Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. , 2001, Cancer research.

[5]  U. Klotz,et al.  Telomere length in different tissues of elderly patients , 2000, Mechanisms of Ageing and Development.

[6]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[7]  A. Risch,et al.  Short Telomeres in Patients with Vascular Dementia: An Indicator of Low Antioxidative Capacity and a Possible Risk Factor? , 2000, Laboratory Investigation.

[8]  J. Shay,et al.  Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang* , 2000, The Journal of Biological Chemistry.

[9]  G. Saretzki,et al.  Telomere Length As a Marker of Oxidative Stress in Primary Human Fibroblast Cultures , 2000, Annals of the New York Academy of Sciences.

[10]  B. van Steensel,et al.  Control of Human Telomere Length by TRF1 and TRF2 , 2000, Molecular and Cellular Biology.

[11]  R. Wurm,et al.  Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments , 1999, Oncogene.

[12]  Nathalie Rufer,et al.  Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood , 1999, The Journal of experimental medicine.

[13]  E. Blackburn,et al.  Telomerase: Dr Jekyll or Mr Hyde? , 1999, Current opinion in genetics & development.

[14]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[15]  G. Saretzki,et al.  Accelerated telomere shortening in fibroblasts after extended periods of confluency. , 1998, Free radical biology & medicine.

[16]  S. Petersen,et al.  Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. , 1998, Experimental cell research.

[17]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[18]  J. Shay,et al.  Normal human chromosomes have long G-rich telomeric overhangs at one end. , 1997, Genes & development.

[19]  K. Oexle,et al.  Advanced telomere shortening in respiratory chain disorders. , 1997, Human molecular genetics.

[20]  J. Langmore,et al.  Long G Tails at Both Ends of Human Chromosomes Suggest a C Strand Degradation Mechanism for Telomere Shortening , 1997, Cell.

[21]  C. Harley,et al.  Telomere length and replicative aging in human vascular tissues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Saretzki,et al.  Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? , 1995, Experimental cell research.

[23]  C. Harley,et al.  Evidence for a critical telomere length in senescent human fibroblasts. , 1995, Experimental cell research.

[24]  D I Boomsma,et al.  Genetic determination of telomere size in humans: a twin study of three age groups. , 1994, American journal of human genetics.

[25]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[26]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[27]  T. Zglinicki,et al.  Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. , 2000, Free radical biology & medicine.

[28]  R. Faragher,et al.  Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts , 2000, Nature Genetics.

[29]  I. Young,et al.  Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. , 1999, QJM : monthly journal of the Association of Physicians.

[30]  Xu-Rong Jiang,et al.  Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype , 1999, Nature Genetics.